New imidazolidinic bioisosters: Potential candidates for antischistosomal drugs

Memorias do Instituto Oswaldo Cruz

Volumn 101, Issue SUPPL. 1, 2006, Pages 313-316

  Pitta, Maira G R ^a   Silva, Andréa C A ^a   Neves, Juliana Kelle A L ^a   Silva, Poliana G ^a   Irmão, João I ^a   Malagueño, Elizabeth ^a   Santana, José V ^a   Lima, Maria C A ^a   Galdino, Suely L ^a   Pitta, Ivan R ^a   Albuquerque, Mônica C P A ^a  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

Author keywords

Imidazolidines; In vitro susceptibility; Schistosoma mansoni

Indexed keywords

MUS; SCHISTOSOMA; SCHISTOSOMA MANSONI;

EID: 33846419549     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762006000900049     Document Type: Conference Paper

References (19)

1. Abass M, Mostafa BB 2005. Synthesis and evaluation of molluscicidal and larvicidal activities of some novel enaminones derived from 4- hydroxyquinolinones: part IX. Bioorg Med Chem 13: 6133-6144.
2. Albuquerque MCA, Silva TG, Pitta MGR, Silva ACA, Silva PG, Malagueño E, Santana JV, Wanderley AG, Lima MCA, Galdino SL, Barbe J, Pitta IR 2005. Synthesis and schistosomicidal activity of new substituted thioxoimidazolidine compounds. Pharmazie 60: 13-17.
3. Bahgat MM, Maghraby AS, Heiba ME, Ruppel A, Fathalla OA 2005. Synthesis of new 4-oxo-2-thioxo-1,2,3,4-tetrahydropyrimidine derivatives with an incorporated thiazolidinone moiety and testing their possible serine protease and cercarial elastase inhibitory effects with a possible prospective to block penetration of Schistosoma mansoni cercariae into the mice skin. Arch Pharm Res 28: 1002-1012.
4. Brandão SSF, Rocha Filho JA, Chantegrel J, Albuquerque JFC, Ximenes EA, Galdino SL, Pitta IR, Perrissin M, Luu-Duc C 1997. Synthèse et structure des arylazo-imidazolidines et et arylidèneimidazolidines substituées. Ann Pharm Françaises 55: 206-211.
5. Cioli D, Pica-Mattoccia L 2003. Praziquantel. Parasitol Res 90: S3-9.
6. Cioli D, Pica-Mattoccia L, Archer S 1995. Antischistosomal drugs: past, present ... and future? Pharmac & Ther 68: 35-85.
7. Cope AC, Hofmann CM, Wyckoff C, Hardenber E 1941. Condensation reactions. II. Alkylidene cyanoacetic and malonic ester. J Am Chem Soc 63: 3452-3456.
8. Davis A, Wegner DH 1979. Multicentre trials of praziquantel in human schistosomiasis: design and techniques. Bull WHO 57: 767-771.
9. Duvall RH, Dewitt WB 1967. An improved perfusion technique for recovering adult schistosomes from laboratory animals. Am J Trop Med Hyg 16: 483-486.
10. Hamed MA, Hetta MH 2005. Efficacy of Citrus reticulata and Mirazid in treatment of Schistosoma mansoni. Mem Inst Oswaldo Cruz 100: 771-778.
11. King CH, Muchiri EM, Ouma JH 2000. Evidence against rapid emergence of praziquantel resistance in Schistosoma haematobium, Kenya. Emerg Infect Dis 6: 585-594.
12. Lima MCA, Costa DLB, Goes AJS, Galdino SL, Pitta IR, Luu-Duc C. 1992. Synthèse et activité antimicrobienne de derives chlorobenzyl benzylidène imidazolidinediones et thiazolidinediones substituées. Pharmazie 47: 182-184.
13. Massoud AM, el Ebiary FH, Ibrahim SH 2005. Light microscopic study of the effect of new antischistosmal drug (myrrh extract) on the liver of mice. J Egypt Soc Parasitol 35: 971-988.
14. Oliveira SM, Albuquerque MCPA, Pitta MGR, Malagueño E, Santana JV, Lima MCA, Pitta IR, Galdino SL 2004. A resposta do Schistosoma mansoni mantido in vitro frente a derivados imidazolidinônicos. Acta Farm Bonaerense 23: 343-348.
15. Oliver L, Stirewalt MA 1952. An efficient method for exposure of mice to cercariae of Schistosoma mansoni. J Parasitol 38: 19-23.
16. Silva IM, Thiengo R, Conceicao MJ, Rey L, Lenzi HL, Pereira Filho E, Ribeiro PC 2005. Therapeutic failure of praziquantel in the treatment of Schistosoma haematobium infection in Brazilians returning from Africa. Mem Inst Oswaldo Cruz 100: 445-449.
17. Simone CA, Pereira MA, Luu-Duc C, Pitta IR, Galdino SL, Menezes EHC, Schpector JZ 1996. 3-benzyl-5-(2-fluorobenzylidene)-imidazolidine-2,4-dione. Acta Christ 52: 2771-2772.
18. Tallima H, Salah M, El-Ridi R 2005. In vitro and in vivo effects of unsaturated fatty acids on Schistosoma mansoni and S. haematobium lung-stage larvae. J Parasitol 91: 1094-1102.
19. WHO-World Health Organization 1993. WHO Technical Report. The control of schistosomiasis: second report of the WHO Expert Committee. Vol. 830. Geneva.